Soleno Therapeutics Inc entered into an underwriting agreement for a public offering of 3,000,000 shares of common stock, with an option for the underwriters to purchase an additional 450,000 shares, and a private placement agreement for the sale of 1,825,000 shares of common stock and pre-funded warrants to purchase 1,175,000 shares of common stock.